DailyIQ
Last updated2 minutes ago

GL·Globe Life Inc.

$172.98
+1.81 (+1.06%)
Overnight$172.92-0.06 (-0.03%)
High
$174.14
Open
$172.60
Market Cap
13.15B
52W High
$191.55
Low
$170.50
P. Close
$172.98
P/E
10.85
52W Low
$127.00
Fwd P/E
10.43
DailyIQ Est.
$199.39
Inst. Ownership
44.8%
Short Interest
2.71%
Days to Cover
4.2
Technical Score (1D)
23
SELL
News Sentiment
47
MIXED
Globe Life’s co‑CEOs announced a Texas‑centric expansion plan just 3.3 hours ago, revealing the opening of a new NYSE Texas headquarters in Dallas. The leadership split—Matt Darden focusing on distribution and Frank Svoboda on finance and administration—underscores a coordinated push to grow agent recruitment and policy issuance in the state. The company’s emphasis on Texas signals a belief that the region’s regulatory environment and talent pool can accelerate growth, even though no new financial guidance was issued. This strategic focus should lift demand for Globe Life’s insurance products over the next 1–10 trading days as the firm ramps up its sales force. Investors should monitor the pace of agent onboarding and the volume of new policies issued in Texas, as these metrics will validate the company’s growth thesis. Additionally, watch for any subsequent guidance releases that may quantify the expected revenue lift from the Texas expansion. The company’s commitment to strengthening its administrative and financial operations in Dallas may also improve operational efficiency, potentially reducing costs. Finally, keep an eye on broader market sentiment toward insurance firms in Texas, as any regulatory changes could impact the rollout of this strategy.
Earnings Summary
Globe Life Inc. is a U.S. life and supplemental health insurer that serves lower‑to‑middle income customers through direct, agency, and independent channels, operating in the life insurance sector of financial services. The company’s core segments—Life Insurance, Supplemental Health Insurance, and Investments—drive its revenue mix, with a focus on whole and term life products and accident, cancer, and critical illness coverages. In recent quarters, Globe Life’s earnings have shown a mixed trajectory. Q4 2024 EPS of $3.14 beat the $3.12 estimate, while Q1 2025 EPS of $3.07 fell short of the $3.24 estimate; Q2 2025 EPS of $3.27 exceeded the $3.25 estimate, and Q3 2025 EPS of $4.81 surpassed the $4.54 estimate. Revenue grew from $1.466B in Q4 2024 to $1.482B in Q1 2025, then to $1.482B in Q2 2025 and $1.513B in Q3 2025, indicating a modest acceleration. The company has consistently beat earnings estimates in three of the last four quarters, though revenue growth has lagged sector norms at a 4.8% CAGR. Historically, Globe Life has maintained steady YoY revenue growth but has experienced occasional EPS misses, suggesting that while premium and investment income support top line expansion, rising operating costs and underwriting pressures can erode profitability. Recent news highlights a $2.5B share repurchase authorization and a $0.33 quarterly dividend, underscoring management’s confidence in its balance sheet but also tightening margin for future earnings growth. Investors should watch the next earnings release for clarity on whether premium growth and underwriting gains will offset expense increases, and monitor the timing and volume of the newly authorized buybacks, as both factors will shape the company’s valuation and risk profile over the next 1‑10 trading days.

EPS

EstBeatMiss
$3.00$3.53$4.07$4.61$5.14Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$4.90 - -
Q2'26$3.79$3.61-4.7%
Q1'26$3.48$3.43-1.3%
Q4'25$3.54$3.39-4.2%
Q3'25$4.54$4.81+5.9%
Q2'25$3.25$3.27+0.8%

Revenue

EstBeatMiss
$1.5B$1.5B$1.6B$1.6B$1.7BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.7B - -
Q2'26$1.6B$1.6B-2.7%
Q1'26$1.6B$1.6B+0.5%
Q4'25$1.6B$1.5B-3.4%
Q3'25 - $1.5B -
Q2'25 - $1.5B -

Market Data

GL Stock Snapshot

SELL23/100
$172.92$0.06 (0.0%)
Market cap
13.15B
P/E ratio
10.8
Day range
$170.50 – $174.14
News sentiment
47/100 · Neutral
Analyst target
$193.91 (+12.1%)
Consensus
Buy · 25 analysts
52-week range+36.2% off low · -9.7% from high
$127.00$191.55
Price $172.92 DailyIQ Est. $199.39

The chart on GL has not stabilised: price is in the upper part of its 52-week range and the trend is still down. Earnings and guidance carry more weight than macro data at this capitalisation.

Behaviour On Record

What GL's own history says about today's numbers

Realized volatility (21d)
20.6% 62nd pct
Below its peak
-7.8%
vs 200-day average
+10.9%
Up days (1y)
54%

Globe Life Inc. is currently running 20.6% annualised volatility over the last 21 sessions. Measured against GL's own 13 years of daily returns rather than a market-wide average, that is the 62nd percentile a little above its own norm, against a typical reading of 18.3%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

GL is trading -7.8% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -15.6%, and the deepest was -55.9% in 2024. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +10.9% from its 200-day moving average. Against every other day in its history, that gap ranks at the 77th percentile a somewhat wider gap than its own norm. Over the past year GL closed higher on 54% of sessions, and it is currently 3 sessions into a rising streak.

On September specifically: over 13 years of records, GL finished the month higher 5 of 13 times, with a median return of -0.8% and an average of -0.2%. Its strongest month historically has been November at +4.5% on average, its weakest March at -2.7%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: GL has opened more than 2% away from the prior close in 118 of 3,267 sessions (3.6% of the time), with the largest gaps running +9.3% and -17.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, GL moved an average of 3.4% in the session after earnings, closing higher 2 of those 3 times, with a median move of +1.5% and a largest of -6.9%.

All figures computed from 3,268 daily closes between 2013-09-16 and 2026-09-14, split-adjusted, recomputed daily. Percentiles are against GL's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of GL's sector?

Globe Life Inc. sits in the Financials sector, currently ranked 5th of 11 GICS sectors by relative-strength rotation score (lagging). Within its narrower Insurance industry group, GL ranks 4th of 15 tracked industries, leading.

Sector rank
#5 of 11
Sector state
Lagging
Sector rotation score
50
Industry rank
#4 of 15

Options Market

What is the options market pricing for GL?

CallsPuts

For Globe Life Inc.'s nearest expiry (2026-09-18, 3 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.00), with at-the-money implied volatility around 3.1%. The options market is pricing roughly a ±0.3% move by that expiry — a range of about $170.68–$171.66.

Put/call ratio (2026-09-18)
0.00
ATM implied volatility
3.1%
Total open interest
6
Expected move by 2026-09-18
±0.3% ($170.68–$171.66)

Analyst Rating Changes

Are analysts turning bullish or bearish on GL?

Keefe, Bruyette & Woods most recently reiterated its rating on Globe Life Inc. to Outperform on Jul 24, 2026 with a price target of $190 (from $192). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Keefe, Bruyette & WoodsOutperform
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Jul 24, 2026Keefe, Bruyette & WoodsMaintainedOutperform$192 → $190
Jul 22, 2026TD CowenMaintainedBuy$215 → $225
Jul 21, 2026JP MorganMaintainedOverweight$181 → $201
Jul 15, 2026Piper SandlerMaintainedOverweight$175 → $200
Jul 13, 2026Evercore ISI GroupMaintainedIn-Line$157 → $176
Jul 13, 2026Keefe, Bruyette & WoodsMaintainedOutperform$180 → $192
Jul 10, 2026JefferiesMaintainedHold$147 → $166
Jul 9, 2026Wells FargoMaintainedOverweight$172 → $193
Jul 6, 2026Morgan StanleyMaintainedOverweight$181 → $208
Jun 23, 2026TD CowenMaintainedBuy$199 → $215
May 26, 2026Piper SandlerMaintainedOverweight$167 → $175
May 21, 2026Morgan StanleyMaintainedOverweight$176 → $181

GL Competitive Positioning

Globe Life Inc. (GL) is tracked alongside these names in Insurance - Life on DailyIQ — ranked by market cap, with today's move alongside.